4D Molecular Therapeutics (FDMT) Net Equity Issued and Repurchased (2020 - 2026)
4D Molecular Therapeutics' Net Equity Issued and Repurchased was $21.84 million in Q2 2026, up 122.7% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, 4D Molecular Therapeutics' Net Equity Issued and Repurchased was $31.65 million through Jun 30, 2026; for FY2025, it was $9.6 million, down 97.1% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -45.8% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $331.41 million in FY2024 (+123.4%), $148.34 million in FY2023 and $114.3 million in FY2021 (-44.2%).
- The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | 4D Molecular Therapeutics | 1.01 Bn | -454.35 Mn | - | 21.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.84 Mn |
| Mar 31, 2026 | 9.81 Mn |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 328.30 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 147.69 Mn |
| Jun 30, 2023 | -758,000.00 |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | -471,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | -875,000.00 |
| Mar 31, 2022 | 875,000.00 |
| Dec 31, 2021 | 114.30 Mn |
| Jun 30, 2021 | -99,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Jun 30, 2020 | 72.46 Mn |
| Mar 31, 2020 | 5,000.00 |
API Access
4D Molecular Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();